Please assess the completion status of the following clinical trial:

Trial Title: Genetic Variants and Chemotherapy-induced Abnormal Thermal Sensation

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 20 years old~* Pathological stage I\~IV for ovarian cancer, stage II\~IV for endometrial cancer, or stage III for colorectal cancer.~* Scheduled to receive adjuvant Paclitaxel/Carboplatin for ovarian or endometrial cancer, or mFOLFOX6 for colorectal cancer.~* Patient willing to provide blood sample for research purposes.~* Ability of the patient to provide informed consent.~Exclusion Criteria:~* Prior treatment with neurotoxic chemotherapy, such as oxaliplatin, cisplatin, carboplatin, taxanes or vinca alkaloids.~* Receiving chemotherapy within 6 months.~* A family history of a genetic or familial neuropathy~* Poor compliance

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: None

Study Arms:
- Patients with endometrial or ovarian cancer (Type: None): None
- Patients with colorectal cancer (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).